Shuai Shi is a Senior Principal Scientist and Group Leader in Vaccine Formulation Development at Pfizer, where they have worked since 2019. With four years of expertise in biologics and vaccine formulation, Shuai has led the development of insulins, monoclonal antibodies, and biosimilars while implementing QbD principles and DOE approaches. Previously, Shuai served as a Principal Scientist at Pfizer from 2017 to 2019 and as an Associate Principal Scientist at Merck from 2015 to 2017. Shuai earned a Ph.D. in Pharmaceutics from the University of North Carolina at Chapel Hill and holds degrees from Nanjing University and Penn State University.
This person is not in any teams
This person is not in any offices